{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-233470","form_type":"8-K","ticker":"CLSDQ","cik":"0001539029","company_name":"Clearside Biomedical, Inc.","filed_at":"2025-10-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.687284+00:00","generated_at":"2026-05-17T04:26:03.583893+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.5,"confidence":"high","headline":"Clearside Biomedical regains Nasdaq minimum bid price compliance via reverse split","bullets":["Received Nasdaq Panel letter on Oct 6, 2025 confirming compliance with Minimum Bid Price Requirement.","Compliance achieved by maintaining closing bid at $1.00+ for 10 consecutive business days after reverse stock split.","Reverse stock split effective Sept 12, 2025 was approved by stockholders and implemented to cure non-compliance.","Non-compliance notice originally received Feb 7, 2025; delisting hearing held Sept 16, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-233470","json":"https://secwatch.observer/filing/0001193125-25-233470.json","markdown":"https://secwatch.observer/filing/0001193125-25-233470.md","text":"https://secwatch.observer/filing/0001193125-25-233470.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1539029/000119312525233470/0001193125-25-233470-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1539029/000119312525233470/clsd-20251007.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T04:26:03.583893+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}